Whitepaper: Overcoming Purification Challenges In Antibody Therapeutics Manufacturing

Complex alternative formats derived from conventional antibody structures, including Fab fragments, Fc-fusion proteins, and bispecific formats, are introducing new challenges into the antibody therapeutics manufacturing workflow. To overcome specific purification challenges associated with these molecules, antibody-subdomain-specific affinity chromatography resins have been developed for a wide range of these novel antibody formats.

Download Document

    Please fill out the information below to request information on the products you selected. If you are already registered, or have requested a quote before, and this information will be filled out for you.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

  • Thermo Fisher is here to help you succeed in taking your discovery to commercial realization. Would you like to have a technical expert contact you to learn more about our affinity chromatography solutions?*
  • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information, transmitting your contact information to selected trusted partners, and customizing your experience based on the data you enter.